| 2018 | Academic Medical Center, Amsterdam (Dr. Nicole van der Wel) | Double trouble for TB | Value Proposition + Lead Development |
| 2018 | University of Groningen, Groningen (Prof. Dr. Oscar Kuipers) | Synergistic action of synthetic D-peptides with vancomycin against major Gram-negative pathogens | Value Proposition |
| 2018 | Hogeschool Utrecht, Utrecht (Dr. Raymond Pieters) | Flavobiotics – novel, topical antibacterials from Flavobacteria | Intellectual Property +
Value Proposition |
| 2018 | Madam Therapeutics BV, Nieuwkoop (Dr. Remko van Leeuwen) | Analytical method development for analysis of SAAP-148 in the drug product | Lead Development |
| 2018 | University Medical Center Utrecht, Utrecht (Dr. Beatrix Förster-Schäfer) | Polyclonal immunoglobulin for cutaneous treatment of infections with Staphylococcus | Value Proposition + Lead Development |
| 2018 | AGILeBiotics BV, Groningen (Dr. Andreas Bastian) | Boosting Drugs against Bad Bugs | Intellectual Property +
Lead Development |
| 2019 | Phage Wound Care BV (Dr. Joris Krijger) | Bacteriophage solution for diabetic feet infections | Intellectual Property + Value Proposition |
| 2019 | University of Groningen, Groningen (Prof. Dr. Oscar Kuipers) | Synergistic action of synthetic D-peptides with vancomycin against major Gram-negative pathogens: drugability and in vivo proof of concept | Lead Development |
| 2019 | University Medical Center Utrecht, Utrecht (Dr. Beatrix Förster-Schäfer) | Polyclonal immunoglobulin for cutaneous treatment of infections with Staphylococcus | Lead Development |
| 2019 | University of Leiden (Prof. Dr. Nathaniel Martin) | Tolerability & efficacy of a novel class of lipidated glycopeptide antibiotics | Lead Development |
| 2019 | Leiden University Medical Center (Dr. Peter Nibbering) | Systemic application of novel antimicrobial peptides from snakes (SNAPS) | Lead Development |
